Studies have shown that the expression level of VEGF in TNBC patients (especially BLIS type) is significantly higher than that in non-TNBC, patients, so anti-angiogenic drugs can effectively stop tumor development, commonly used bevacizumab,apatinib, etc. (3, 14). This evidence concerns the gene VEGFA and neoplasm.